<DOC>
	<DOCNO>NCT01404962</DOCNO>
	<brief_summary>This multicenter , post marketing surveillance study aim evaluate safety profile haemophilus influenza type b vaccine administer Korean child accord product insert .</brief_summary>
	<brief_title>Safety Haemophilus Influenza Type b Vaccine When Administered Korean Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female child 2 month 5 year age schedule receive vaccination Contraindications Vaxemâ„¢Hib Korean Prescribing information</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Haemophilus influenza type b</keyword>
	<keyword>child</keyword>
	<keyword>Korea</keyword>
	<keyword>vaccine</keyword>
	<keyword>Prevention haemophilus influenza type b</keyword>
</DOC>